leading glp-1 treatments for diabetes 2025 Puerto Rico leads U.S. growth in prescriptions in Poll: 1 in 8 Adults

Poor pregnancy outcome in women with type 2 diabetes

Were passing that access and value along to our customers, who deserve the highest standard of clinical safety and efficacy to meet their goals, and we're doing it in a safe, affordable way that others cant deliver." According to the US Food and Drug Administration (FDA), around 70% of American adults have obesity or are overweight, and losing 5 to 10% of that body weight can reduce weight-related health risks, such as diabetes and cardiovascular disease

A variant in TCF7L2 , tied to glucose homeostasis and GLP-1 secretion, or in FTO , GLP1R , and MC4R , maps the metabolic terrain any GLP-1 compound acts on

Receptors 4, 2 (2025).

The regulatory landscape is also evolving

Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats